2025 AACR Annual Meeting: In April, Sutro presented encouraging preclinical results from STRO-004 and its dual-payload ADC programs. Notably, a single dose of STRO-004 produced promising overall ...

Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025Fast Track ...

Last week, the Senate Appropriations Committee released a report on the country’s federal labor, health, human services, and ...

Total revenues decreased $6.9 million year over year to $481.2 million but increased $58.2 million sequentially versus the first quarter of 2025 Construction Equipment and Master Distribution revenues ...

Financial Results for First Quarter Ended June 30, 2025 Compared to June 30, 2024 Revenue increased 5% to $13.3 million, compared to $12.6 million in the second quarter of 2024. Cost of revenue was $2 ...

Second quarter revenue increased to $15.4 million compared to $13.0 million for the second quarter of 2024. < ...